In the world of pharmaceutical manufacturing, our robotic isolator technology sets a new standard for aseptic fill-finish technology. By integrating process equipment and isolator into a single-source supply, roboFIL™ streamlines implementation and simplifies project delivery. Engineered with cutting-edge robotics, roboFIL™ handles complex demands of aseptic liquid and powder filling with unparalleled precision. This breakthrough technology is a testament to the evolving landscape of pharmaceutical manufacturing, where innovation is a necessity.
One integrated system
With 100% inspection levels and advanced reject management, the system not only ensures compliance with stringent regulatory standards but also enhances the overall reliability of the aseptic process.
By integrating process equipment and isolator into a single-source supply, roboFIL™ simplifies technical support, eliminating the complexity typically associated with aseptic fill-finish operations.
Pharmaceutical production is not a one-size-fits-all operation. Each product requires unique handling and filling specifications; roboFIL™'s design reflects this reality. Its vision-guided robotic system is compatible with a variety of RTU-based products (including vials, syringes, and cartridges). This flexibility allows for quick format changeover and the introduction of new formats within hours, providing a highly adaptable solution.
roboFIL™ features compact, modular chambers that enable configurable aseptic fill-finish solutions tailored specific process requirements.
roboFIL's™ ability to handle both powder and liquid on a single platform enhances its versatility. This is beneficial for products that require reconstitution before administration, offering flexibility in therapeutic settings. By integrating our Fill2Weight Gravimetric Powder technology, roboFIL™ can handle exceptionally challenging powder properties. Our proven Liquid Fill-Finish Technology can be integrated for liquid filling.
In today's environmentally conscious world, pharmaceutical companies are under increasing pressure to minimise their ecological footprint. roboFIL™ addresses this challenge by incorporating sustainable practices into its design.
The system's air recirculation technology reduces energy consumption by drawing air from the cleanroom and recirculating it, significantly lowering the energy required for operation.
roboFIL™ eliminates the need for washing ready-to-use (RTU) vials on the line, reducing water/steam usage. This not only cuts down on energy consumption but also minimises waste generated during the process.
With a compact footprint and small filling chambers, roboFIL™ requires less air volume management, which further decreases energy consumption and reduces the need for vaporised hydrogen peroxide (VPHP) during decontamination cycles.
These features underscore our commitment to sustainable manufacturing practices, making roboFIL™ an ideal choice for companies looking to enhance their environmental stewardship.
Automation is at the heart of roboFIL's design, driving significant improvements in production efficiency. The system's revolving door allows simultaneous loading and unloading of RTU tubs, reducing downtime.
We removed bowl feeders entirely. Instead, a clever vision pick-and-place technology allows for fast-format changeover to reduce setup times.
In pharma, quality is non-negotiable. roboFIL's advanced technology ensures critical requirements are consistently met. roboFIL™'s design incorporates robust contamination control strategies, minimising the risk of product contamination and ensuring compliance with Annex 1 regulations.
Choosing roboFIL™ is not just about acquiring advanced technology - it's about partnering with 3P innovation for comprehensive support throughout the product's lifecycle. From installation to ongoing maintenance, our dedicated Customer Care team is committed to ensuring the long-term reliability and performance of roboFIL™ systems.
With a range of support services backed by our Equipment Support Team, we provide the expertise and assistance needed to maintain optimal production efficiency and quality. This partnership approach allows pharmaceutical manufacturing companies to focus on their core operations, confident in the knowledge that their aseptic fill-finish needs are in expert hands.
roboFIL™ aseptic fill-finish processes are engineered to deliver efficiency, sustainability, and adaptability. By embracing advanced automation and prioritising quality and compliance, roboFIL™ is shaping the future of pharmaceutical manufacturing, enabling companies to meet the evolving demands of the industry while reducing their environmental impact. Partnering with 3P innovation offers a strategic advantage, providing the support and expertise needed to thrive in a competitive market.